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Introduction: The immunomodulatory properties of human amnion epithelial cells (hAECs) have been previously
described in several disease models. We previously reported on the ability of hAECs to influence macrophage
phenotype and chemotaxis. In this study, we aim to elucidate the contribution of regulatory T cells (Tregs) to
macrophage polarisation and downstream effects on inflammation and fibrosis in a bleomycin model of lung injury.
Methods: Either CD45+/FoxP3+ Tregs or CD45+/FoxP3− non-Tregs were adoptively transferred into Rag1−/− mice
immediately prior to bleomycin challenge. Four million hAECs were administered 24 hours later. Outcomes were
measured 7 or 14 days later.
Results: Mitigation of lung inflammation and fibrosis was observed only in animals that received both hAECs and
Tregs. hAEC treatment also induced the maturation of non-Tregs into FoxP3-expressing Tregs. This event was found to
be transforming growth factor-beta (TGFβ)-dependent. Furthermore, polarisation of macrophages from M1 to M2
occurred only in animals that received hAECs and Tregs.
Conclusions: This study provides the first evidence that Tregs are required for hAEC-mediated macrophage polarisation
and consequential mitigation of bleomycin-induced lung injury. Uncovering the interactions between hAECs,
macrophages, and T-cell subsets is central to understanding the mechanisms by which hAECs elicit lung repair.Introduction
Gestational tissues, including the placenta and fetal
membranes, are abundant sources of stem cells and
stem-like cells. Possibly reflective of the maternal status,
these cells also bear potent immunomodulatory proper-
ties. Fetal derived mesenchymal stromal cells (MSCs)
have a greater ability to suppress antigen-specific T-cell
proliferation compared with maternal MSCs [1]. Both
amniotic membrane-derived MSCs and human amnion
epithelial cells (hAECs) are able to inhibit dendritic cell
differentiation [2] We, and others, have previously re-
ported that hAECs exert protective and pro-reparative
effects in the settings of lung [3-7], liver [8,9], and* Correspondence: rebecca.lim@monash.edu
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unless otherwise stated.neurological [10-12] diseases. Unlike many stem cells
and stem-like cells, hAECs can be isolated from amni-
otic membranes in numbers sufficient for clinical use
(approximately 150 to 200 million) within 6 hours with-
out the need for serial passaging [13,14]. This may be an
advantageous attribute given the recent reports that ser-
ial passaging can result in epigenetic changes [15-17]
and genomic mutations [18] as well as compromise im-
munomodulatory capabilities [2].
Although there have been some reports of hAEC en-
graftment [4,9], this may not be a major mechanism of
hAEC action. Similar to recent reports in the field of
MSC research, hAECs appear to exert their effects pri-
marily via paracrine signaling rather than functional cell
engraftment. There are now reports describing the bio-
logical effects of hAEC-conditioned media, such as the
ability to influence the phagocytic ability and polarity of
macrophages [10] and the fibrogenic/fibrolytic balance
in hepatic stellate cells [19]. Indeed, it appears thatis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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effects in the presence of functional macrophages [20].
This is perhaps not surprising since endogenous lung
macrophages play a central role in the regulation of the
immune response to injury. For example, macrophages
are able to induce the generation of regulatory T cells
(Tregs) from naïve CD4+ T cells [21]. Reciprocally, Tregs
have been reported to induce a phenotypic and func-
tional switch in macrophage polarity [22].
Given that Tregs have also been shown to be important
in resolving lung inflammation and fibrosis by reducing
fibrocyte recruitment, we set out to explore whether hAEC
treatment altered the Treg population and whether hAEC
polarisation of macrophages is dependent on Treg activity.
Furthermore, we asked which cytokines were key to the
reparative events that we had previously observed. Using
transgenic FoxP3-GFP mice and Rag1−/− mice, we per-
formed a series of adoptive transfer studies and in vitro co-
culture studies to answer these questions. In the recent Na-
tional Institutes of Health (NIH) workshop on Cell Therapy
for Lung Disease, understanding the mechanism of action
and identifying cellular targets were listed as research prior-
ities [23]. Furthermore, guidelines from the Therapeutic
Goods Administration (Australia) on biologicals, including
cell therapies, state that “even where the mechanism of
action is not understood in detail, the main effects of the
biological should be known” [24]. With these consider-
ations, further delineating immunological events following
hAEC administration represents an important step in
translating this research to the clinic.Methods
Human amnion epithelial cell isolation
Placentae were collected from consented patients
undergoing elective caesarean sections at term. Isolation
of hAECs was performed as previously described [14]
in accordance with guidelines and approval from the
Southern Health Human Research Ethics Committee.
Amnions collected had a mean gestational age of 38 weeks.
In total, 14 amnions were used in this study: six for animal
injections and eight for in vitro experiments.Figure 1 Human amnion epithelial cell (hAEC)-mediated repair
following bleomycin challenge is associated with regulatory T
cell (Treg) expansion. (A) Experimental timeline for basic bleomycin
studies. (B) The FoxP3+ Treg population was unchanged by bleomycin
challenge but was increased in animals that received hAECs. **P <0.01.Mice
All animal experiments were approved by the Monash
University Animal Ethics Committee and conducted in
accordance with the Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes. In
total, 150 female mice 8 to 12 weeks old were used.
Rag1−/− mice were sourced from Animal Resources
Centre, Australia, and Foxp3-GFP mice from Alex
Rudensky, University of Washington. Mice were ran-
domly divided into eight groups as listed below and
summarised in Figure 1A. On average, six mice wereused per group for flow cytometry, seven per group for
histology, and six per group for protein and gene ana-
lyses. Animals were humanely culled 7 or 14 days later.
Saline controls: Intranasal (IN) saline instillation and
intraperitoneal (IP) injection of saline 24 hours later;
Bleomycin controls: IN bleomycin instillation and IP
injection of saline 24 hours later;
Saline + hAECs: IN saline instillation and IP injection
of 4 million hAECs 24 hours later;
Bleomycin + hAECs (hAECs alone): IN bleomycin in-
stillation and IP injection of 4 million hAECs 24 hours
later;
Tregs + bleomycin + saline (Tregs alone): Intravenous
(IV) injection of 0.5 million FoxP3+ Tregs and an IN instil-
lation of bleomycin followed by an IP injection of saline
24 hours later;
Tregs + bleomycin + hAECs (Tregs + hAECs): IV in-
jection of 0.5 million FoxP3+ Tregs and an IN instillation
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hAECs 24 hours later;
non-Tregs + bleomycin + saline (non-Tregs alone):
IV injection of 0.5 million CD45+FoxP3− non-Tregs and
an IN bleomycin instillation followed by an IP injection
of saline 24 hours later;
non-Tregs + bleomycin + hAECs (non-Tregs + hAECs):
IV injection of 0.5 million CD45+FoxP3− non-Tregs and an
IN bleomycin instillation followed by an IP injection of 4
million hAECs 24 hours later.
Isolation of cells for adoptive transfer
Spleens from Foxp3-GFP transgenic mice were homoge-
nised to obtain a single cell suspension. Cells were re-
suspended in magnetic-activated cell sorting (MACS)
buffer after red blood cell lysis. CD4+ cells were enriched
the CD4+ T-cell enrichment kit II (130-095-248; MACS
Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) in
accordance with the guidelines of the manufacturer.
FoxP3+ cells (Tregs) were obtained from the CD4+
enriched population, whereas CD45+ FoxP3− cells were
obtained from the CD4− fraction. FoxP3+ cells were flow-
sorted according to their GFP expression. Gating strategy
is described in the online data supplement (Figure S1 in
Additional file 1). CD45+ (1:300, 560501; BD Biosciences,
Franklin Lakes, NJ, USA) were obtained by a flow-sorting
Mo-Flow™ XDP High-Speed cell sorter (Beckman Coulter,
Brea, CA, USA). Sorted cells were resuspended in saline
to obtain 0.5 × 106 cells in 200 μL.
Tissue collection
After mice were culled, bronchoalveolar lavage fluid was
collected from each animal in 1.5 mL of saline by using
a 19-gauge blunt needle. Lung tissues were divided
equally for measuring immunohistochemical and protein
outcomes as previously described [3]. Both lungs were
collected from an identical cohort of animals to deter-
mine macrophage polarity and function.
Histological and immunohistochemical analysis
Tissue collection and processing
To perfuse the left lung, the right lung was ligated at the
mainstream bronchus and 4% paraformaldehyde was in-
stilled into the left lung through an incision in the tra-
chea. The lungs were filled at 20 cm of water pressure.
For paraffin-embedded blocks, lung tissue was trans-
ferred into 70% ethanol for 24 hours prior to processing.
For frozen lung sections, lung lobes were transferred
into 30% sucrose solution and stored at 4°C for 48 hours
to allow complete diffusion of the solution. The tissues
were transferred into 80% Tissue-Tek optimal cutting
temperature (OCT) compound (Sakura Finetek, Leiden,
Holland) diluted with 30% sucrose solution and keptunder vacuum for 24 hours. Tissues were embedded in
OCT compound for cryosectioning.
Lung morphology
Paraffin-embedded lung sections of 5-μm thickness were
stained by using hematoxylin and eosin, and 20 to 25 se-
quential fields of view (200× magnification) were cap-
tured by using brightfield light microscopy (AxioSkop,
Carl Zeiss, Oberkochen, Germany) for tissue-to-airspace
analysis using the Image J software package (NIH,
Bethesda, MD, USA) as previously described [8].
F480 immunohistochemistry
Immunohistochemical detection of macrophages was
performed as previously described [10]. Immunostaining
was performed by using a rat anti-mouse F480 monoclo-
nal primary antibody (1:200, MCA497R; Serotec, Oxford,
UK) and biotinylated goat anti-rat IgG (1:100, AP183β;
Millipore, Billerica, MA, USA). For analysis, 20 to 25 se-
quential fields of view (200× magnification) were cap-
tured and Metamorph software (Molecular Devices,
Sunnyvale, CA, USA) was used to determine total num-
bers of nuclei and F4/80+ cells.
Foxp3 immunofluorescence
Immunohistochemical detection of GFP-tagged Foxp3+
Tregs was performed by using fluorescent microscopy
on cryosections. True staining was confirmed by co-
localisation of chicken anti-GFP (1:1,000, GFP-1020;
Aves Labs, Inc., Tigard, OR, USA) with GFP over nu-
clear staining (4′,6-diamidino-2-phenylindole, or DAPI)
and absence of auto-fluorescence in the red channel.
Lung collagen quantification
Collagen content was determined by using the Sircol™
Collagen Assay (catalogue #S1000; Biocolor, Carrickfer-
gus, UK). Homogenised lung tissues were analysed in ac-
cordance with the guidelines of the manufacturer.
Flow cytometric analysis
Lung tissues were minced and digested in Waymouths
media (Invitrogen, Carlsbad, CA, USA) containing
25 mg/mL collagenase A (Roche Diagnostics, Mann-
heim, Germany), 2.5 mg/mL of DNase I (Sigma-Aldrich,
St. Louis, MO, USA), 25 mM Hepes (Sigma-Aldrich),
and 10% heat-inactivated fetal bovine serum (Invitrogen)
for 15 minutes at 37°C and 5% CO2. Cells were incubated
with an Fc-receptor blocker (553141; BD Pharmingen) for
15 minutes on ice and stained with the following anti-
bodies: CD45-V450 (1:150, 560541; BD Biosciences, North
Ryde, NSW, Australia), F4/80-PE (1:100, 12-4321-82;
eBioscience, San Diego, CA, USA), CD86-PE Cy-7 (1:200,
560501; BD Biosciences, San Jose, CA, USA), and CD206-
Alexa Fluor 647 (1:200, 12310; Australian Biosearch,
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by using FlowJo cytometric analysis software (Tree Star,
Ashland, OR, USA). For gating strategy, see Figure S2 in
Additional file 1 in the online data supplement.
In vitro studies
CD4+ T-cell co-culture with human amnion epithelial cells
Splenocytes from FoxP3-GFP mice were obtained as de-
scribed above. Cells were plated at 2.5 × 106 in the anti-
CD3 (MAB484; R&D Systems, Minneapolis, MN, USA,
10 μg/mL) pre-coated bottom chamber of a sixwell plate
and treated with anti-CD28 (553294; BD Pharmingen,
2 μg/mL) to activate T cells as previously described [13].
Five million hAECs were added to the top chamber and
cultured for 5 days prior to flow cytometry.
CD4+ T-cell co-culture with human amnion epithelial
cell-pretreated macrophages
CD4+ T cells were indirectly co-cultured hAEC-pretreated
or non-pretreated macrophages for 5 days by using
transwell inserts (0.4 μm; BD Falcon, Franklin Lakes, NJ).
FoxP3 transcription was determined by flow cytometric
detection of GFP expression. Co-culture details are
described in the online supplementary methods. Where
appropriate, recombinant transforming growth factor-beta
(TGFβ) (240-B-001MG/CF; R&D Systems, 5 ng/mL) was
added to CD4+ FoxP3− (non-Treg) cell cultures as a posi-
tive control. To assess the contribution of hAEC-derived
TGFβ to Treg expansion, anti-TGFβ blocking antibody
(2939, 1 mg/mL; Tocris Bioscience, Bristol, UK) was added
to cultures to block TGF-β-mediated Foxp3 expansion.
Cytokine analysis
Concentrations of TGFβ1, interleukin-4 (IL-4), and
prostaglandin E2 (PGE2) in the culture supernatant were
determined by using commercially available kits. TGFβ1
(560429; BD Biosciences, San Diego, CA, USA), IL-4
(MBS705670; MyBiosource, San Diego, CA, USA), and
PGE2 (514010; Caymen Chemical, Ann Arbor, MI,
USA). Primer sequences used for quantitative polymer-
ase chain reaction are as follows: IL-4: forward TGT
CCA CGG ACA CAA GTG CGA, reverse TCT CAT
GAT CGT CTT TAG CCT TTC C; Cox 2: forward CCA
CCC GCA GTA CAG AAA GT, reverse CAG GAT
ACA GCT CCA CAG CA; and TGF-β: forward CCC
TGG ACA CCA ACT ATT GC, reverse GCA GAA
GTT GGC ATG GTA GC. Cycling conditions were 95°C
for 5 minutes, 60°C for 25 seconds for 35 cycles.
Statistical analysis
Data were expressed for each experimental group as
mean ± standard error of the mean. Statistical signifi-
cance was determined with GraphPad Prism (GraphPad
Software, Inc., San Diego, CA, USA). Differences betweentwo experimental groups were determined by using an un-
paired, one-tailed t test. Differences across three or more
experimental groups were determined by using one-way
analysis of variance with the Bonferroni post hoc test. Con-
fidence intervals of 95% were deemed significant.
Results
Human amnion epithelial cell treatment increased
regulatory T cell numbers in the lung
Given the established role of Tregs in the resolution of
lung fibrosis [15,17], we evaluated the effects of hAECs
in bleomycin-injured FoxP3-GFP mice, where FoxP3+
Tregs express GFP. When hAECs were administered
24 hours following a single bleomycin challenge, we ob-
served a significant increase in the percentage of CD45+
FoxP3+ cells (Tregs) in the lung 7 days following bleo-
mycin challenge (Figure 1B, 2.26 ± 0.25 versus 1.11 ±
0.28, P = 0.006). We suggest that this observation is con-
sistent with the association of hAEC-mediated lung re-
pair with either the recruitment of peripheral Tregs to
the lung or the inducement of the in vivo expansion or
conversion of resident Tregs within the lung.
Human amnion epithelial cells require regulatory T cells to
mitigate bleomycin-induced lung fibrosis in Rag1−/− mice
To examine the role of Tregs in hAEC-mediated lung re-
pair, we administered hAECs into bleomycin-challenged
Rag 1−/− mice and assessed changes to the tissue-to-
airspace ratio, an indicator of lung architectural damage
and inflammatory cellular infiltrate. Fourteen days follow-
ing bleomycin challenge, tissue-to-airspace ratio and colla-
gen content in the lungs increased as expected. hAEC
treatment modestly reduced the tissue-to-airspace ratio in
Rag 1−/− mice (Figure 2A, 24.06 ± 2.23 versus 17.00 ± 2.35,
P = 0.017). Representative images of lung histology are
depicted in Figure 2B. Collagen content remained un-
changed by hAEC administration (Figure 2C, 550.3 ±
41.82 versus 540.9 ± 115 μg/mL, P = 0.94).
When Tregs were adoptively transferred prior to
hAEC administration (Treg + hAEC), both tissue-to-
airspace ratio and lung collagen content were markedly
reduced compared with bleomycin controls (tissue-to-
airspace ratio 8.4 ± 1.0 versus 27.26 ± 2.7, P = 0.002; col-
lagen content 210.0 ± 10.9 versus 540.9 ± 115.0 μg/mL,
P = 0.02). Tissue-to-airspace ratio and lung collagen con-
tent were also lowered in the Treg + hAEC group com-
pared with hAECs alone (tissue-to-airspace ratio 8.4 ±
1.0 versus 17.0 ± 2.4, P = 0.01; collagen content 210.0 ±
10.9 versus 550.3 ± 41.9.0 μg/mL, P <0.0001), suggesting
that Tregs play a role in hAEC-mediated mitigation of
bleomycin-induced lung injury. These effects were not
observed in animals receiving only adoptively transferred
Tregs and no hAECs (tissue-to-airspace ratio 21.88 ±
5.42, P = 0.31; collagen content 481.2 ± 89.3, P = 0.69).
Figure 2 (See legend on next page.)
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Figure 2 Regulatory T cells (Tregs) are required for human amnion epithelial cell (hAEC)-mediated repair of bleomycin-induced lung
injury in Rag1−/− mice. (A) Administration of bleomycin into Rag1−/− mice resulted in a significant increase in tissue-to-airspace ratio. A small
reduction was observed following hAEC administration alone. Tissue-to-airspace ratio was lowest in the Treg + hAEC group, and this was significantly
lower compared with groups given either Tregs or hAECs (*P <0.05, **P <0.01, ***P <0.001). (B) Representative images of hematoxylin-and-eosin-stained
lung sections were taken at 200× magnification (scale bar = 100 μm). (i) Saline, (ii) saline hAECs, (iii) bleomycin, (iv) bleomycin hAECs, (v) CD45+
bleomycin saline, (vi) CD45+ bleomycin hAECs, (vii) Tregs bleomycin saline, (viii) Tregs bleomycin hAECs. (C) At day 14, bleomycin administration
significantly increased total lung collagen content. Co-administration of Tregs and hAECs significantly reduced lung collagen content in comparison
with control groups given hAECs or Tregs alone (*P <0.05, **P <0.0001). (D) Macrophages were identified by F4/80 staining and were quantified at
day 7. Bleomycin administration resulted in a significant increase in macrophage numbers, but administration of hAECs alone had no significant effect.
The number of macrophages in the lungs was reduced only in the Treg + hAEC group (**P <0.01).
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referred to as ‘non-Tregs’) prior to hAEC treatment was
also associated with some mitigation of increased tissue-
to-airspace ratio (12.23 ± 2.61, P = 0.002) but not colla-
gen deposition (473.9 ± 55.63 μg/mL, P = 0.59).
From these observations, we suggest that hAECs re-
quire the presence of Tregs to affect their injury pre-
ventative effects following bleomycin administration.
Given the previous findings that hAECs reduced macro-
phage infiltration to the lungs and its association with
mitigation of acute injury, we next asked whether hAECs
were able to modify macrophage responses to bleomycin-
induced injury in Rag1−/− mice in the absence of mature
lymphocytes. We determined that hAEC administration
alone failed to reduce macrophage infiltration in Rag 1−/−
mice 7 days following bleomycin challenge (Figure 2D,
5.41 ± 1.84 versus 3.76 ± 1.14%, P = 0.22). However, the re-
cruitment of macrophages to the lungs was completely
abolished in the animals that received hAECs after adop-
tive transfer of Tregs (0.34 ± 0.12%, P = 0.008 versus bleo-
mycin controls). This was not achieved by adoptive
transfer of Tregs alone (7.01 ± 1.76%, P = 0.07 versus
bleomycin controls) or non-Tregs + hAECs (1.72 ±
0.47%, P = 0.11 versus bleomycin controls).
Human amnion epithelial cells promote FoxP3
transcription in vivo
In light of the protective effects of hAECs in Rag1−/− an-
imals that had received non-Tregs (Figure 2A) and the
central role that Tregs are thought to have in lung repair
[25,26], we wondered whether hAECs were able to dif-
ferentiate CD45+FoxP3− non-Tregs into FoxP3+ Tregs.
To explore this, we analysed lung sections of Rag1−/−
mice that received non-Tregs with or without hAECs.
We detected GFP+ cells only in those animals receiving
both non-Tregs and hAECs and not in animals receiving
non-Tregs alone (representative images in Figure 3A).
The overlap of GFP expression with DAPI, concomitant
with absent auto-fluorescence in the red channel, con-
firmed true expression of Foxp3.
We observed a small increase in GFP+ cells in the
lungs of mice that received non-Tregs (0.17 ± 0.17 versus
0.00 ± 0.00%, P = 0.19, Figure 3B). This suggests that aproportion of the non-Tregs may have acquired a
FoxP3+ phenotype in vivo following hAEC administra-
tion. Additionally, the percentage of Tregs in the lung
was fivefold higher in Treg + hAEC animals compared
with Tregs alone (Figure 3B, 1.92 ± 0.37 versus 0.40 ±
0.24%, P = 0.0052). These findings are consistent with
the administration of hAECs promoting the in vivo ex-
pansion or recruitment (or both) of Tregs to the lung
and the differentiation of non-Tregs into Tregs.
Human amnion epithelial cells require regulatory T cells
to polarise macrophages toward an M2 phenotype
It is known that hAECs can directly polarise pro-
inflammatory M1 macrophages into pro-reparative M2
macrophages in vitro without the presence of T cells
[10]. Accordingly, we evaluated the polarity of macro-
phages in the lungs in each of our experimental cohorts.
In C57Bl6 mice, hAEC treatment significantly reduced
pro-inflammatory M1 (CD86+) macrophages (Figure 4A,
1.31 ± 0.42 versus 8.11 ± 1.77%, P = 0.004). In Rag1−/−
mice, the percentage of M1 macrophages (CD86+) in the
lungs was reduced only in animals that received Tregs
and hAECs (2.70 ± 1.71 versus 4.17 ± 0.17%, P = 0.28). In
comparison, we observed increases in the percentage of
CD86+ M1 macrophages following adoptive transfer of
Tregs alone (10.66 ± 1.40%, P = 0.008), non-Tregs alone
(12.86 ± 1.97, P = 0.009), and non-Tregs with hAECs
(9.62 ± 0.81%, P = 0.001).
In C57Bl6 mice, we observed an increase in M2 macro-
phages (CD206+) following hAEC treatment (Figure 4B,
2.86 ± 0.26 versus 0.31 ± 0.008%, P <0.0001). In Rag 1−/−
mice, the percentage of M2 lung macrophages was highest
in Treg + hAEC animals where the M2 macrophages were
approximately 30-fold higher compared with bleomycin
controls (Figure 4B, 1.476 ± 0.23 versus 0.05 ± 0.01, P =
0.002). The percentage of M2 macrophages was also sig-
nificantly increased in non-Treg + hAEC animals com-
pared with bleomycin controls (0.56 ± 0.15%, P = 0.02).
Representative images of immunofluorescence staining
for CD86+ (pink) and CD206+ (white) macrophages are
shown in Figure 4C.
We confirmed the M1/M2 phenotypes of flow-sorted
macrophages by quantitative reverse transcription-
Figure 3 Human amnion epithelial cells (hAECs) induce transcription of FoxP3+ in non-regulatory T cells (non-Tregs) and promote Treg
expansion in vivo. (A) Representative images of green fluorescent protein-positive (GFP+) cells within the lung parenchyma of Rag1−/− mice following
adoptive transfer of Tregs (scale bar = 50 μm) (DAPI, blue; FoxP3, green; auto-fluorescence, red). Green staining in the absence of co-localisation with red
indicates that the cells are GFP+ Tregs rather than autofluorescent cells. (B) Co-administration of hAECs and adoptive transfer of Tregs resulted in
expansion of Tregs in vivo as well as some conversion of non-Tregs into GFP-expressing FoxP3+ Tregs (**P <0.01). DAPI, 4′,6-diamidino-2-phenylindole.
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associated gene, CCL4, was significantly reduced in Treg
alone and Treg + hAEC animals (Figure 4D, P <0.0001),
but NOS-2 and IL-1β were not significantly altered. In
contrast, M2-associated genes arginase-1 (ARG1), found
in inflammatory zone protein-1 (FIZZ1), and YM1 were
consistently elevated in lung macrophages flow-sorted
from Treg + hAEC animals (Figure 4D, P = 0.018, P =
0.018, P = 0.017, respectively). Furthermore, the highest
phagocytic activity was observed in macrophages iso-
lated from Treg + hAEC animals (Figure 4E). Our obser-
vations indicate that Tregs play a role in the in vivo
modulation of macrophages by hAECs.
To explore whether, reciprocally, macrophages had a
role in the effects of hAECs on T cells, we co-cultured
hAEC-primed macrophages (that is, macrophages
polarised by hAECs to an M2 phenotype) with non-
Tregs cells. We observed no increase in FoxP3 transcrip-
tion (Figure 4F), suggesting that in vivo Treg induction was
unlikely to be mediated by hAEC-primed macrophages.
Human amnion epithelial cells promote regulatory T cell
induction via transforming growth factor-beta
To determine whether hAECs directly induced FoxP3+
transcription in naïve CD4+ T cells, we co-cultured
hAECs with naïve CD4+ T cells isolated from unchal-
lenged healthy mice. FoxP3+ transcription was signifi-
cantly increased after 5 days of co-culture (Figure 5A,1.0 ± 0.20 versus 1.62 ± 0.17, P = 0.02). This was com-
pletely prevented by blocking TGFβ signaling (0.32 ±
0.06, P <0.0001). hAECs increased secretion of TGFβ1
upon co-culture with CD4+ T cells (Figure 5B, P = 0.03).
This was concurrent with increased TGFβ transcription
upon stimulation with inflammatory cytokines interferon-
gamma (IFNγ) and tumour necrosis factor-alpha (TNFα)
(Figure 5C, P = 0.031). These observations are consistent
with hAECs increasing TGFβ production when exposed
to inflammatory stimuli, which induces Tregs. Given that
the release of IL-4 by hAECs has been associated with re-
duction in monocyte release of pro-inflammatory cyto-
kines [27], we also measured IL-4 released by hAECs
following stimulation with IFNγ and TNFα. However, we
did not observe any changes to gene transcription or se-
cretion of IL-4 by hAECs (data not shown).
Discussion
Regenerative medicine—in particular, cell-based therap-
ies—is gaining momentum at a remarkable pace. Over
27,700 clinical trials involving cell therapy were regis-
tered on the ClinicalTrials.gov database when this article
was under preparation. Clearly, as the potential of cell
therapy becomes realised and as research translates from
discovery to clinical testing, there is an increasing need
to clearly define the mechanisms of stem cell action. In
this study, we used a well-established mouse model of
lung injury to assess the effect of hAECs on key cellular
Figure 4 (See legend on next page.)
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Figure 4 Human amnion epithelial cell (hAEC) and regulatory T cell (Treg) administration polarise macrophages toward and M2 state
in Rag1−/−. (A) hAEC administration reduced CD86+ M1 macrophages in C57Bl6 mice but not in Rag 1−/− mice. M1 macrophages were significantly
increased in the lungs of animals that received Tregs alone, non-Tregs alone, and non-Tregs + hAECs (**P <0.01), but this was not observed in animals
that received Tregs + hAECs. (B) CD206+ M2 macrophages were significantly increased in Rag 1−/− animals that received Tregs + hAECs (**P <0.01) and,
to a lesser extent, non-Tregs + hAECs (*P <0.05). This trend was similar to that seen in C57Bl6 mice, in which hAEC treatment significantly increased
CD206+ macrophages in the lungs (****P <0.0001). (C) Representative image of CD86+ and CD206+ macrophages between groups with adoptively
transferred cells (scale bar = 200 μm, DAPI, blue; F4/80, green; CD86, pink; CD206, white). These findings were supported by similar changes to the
M1- and M2-specific gene expression. (D) Co-administration of Tregs and hAECs significantly increased transcription of M2-specific genes found in
inflammatory zone protein-1 (FIZZ-1) and Ym-1 (P <0.05) (*p<0.05, ****p<0.0001). (E) Adoptive transfer of Tregs to Rag1−/− mice significantly reduced
phagocytic activity of lung macrophages (*P <0.05); however, increased phagocytic activity was observed in macrophages from Treg + hAEC animals
compared with Tregs alone (**P <0.001). hAEC priming of macrophages did not alter FoxP3 transcription when the macrophages were co-cultured with
CD4+ cells. (F) CD4+ cells were cultured with transforming growth factor-beta (TGFβ) (5 ng/mL) as a positive control. DAPI, 4′,6-diamidino-2-phenylindole.
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and fibrosis.
We showed that the administration of hAECs in-
creased Treg expansion in the lungs of C57Bl6 mice and
this event was coincident with reduced lung injury.
Using Rag1−/− mice, we determined that the presence of
Tregs is central to the reparative effects of hAECs
in vivo. The increase in pulmonary Tregs may be partly
attributed to induction of FoxP3 transcription in naïve T
cells by hAECs, which we showed to be directed mainly
by hAEC-derived TGF-β. Consistent with the limited
lung repair observed in Rag1−/− mice, hAECs were also
unable to polarise macrophages from M1 to M2 in the ab-
sence of adoptively transferred Tregs. Since macrophageFigure 5 Human amnion epithelial cells (hAECs) induce regulatory T c
(TGF-β1). (A) Co-culture of FoxP3− non-Tregs with hAECs induced FoxP3 t
wholly ameliorated by the addition of an anti-TGFβ blocking antibody (1 mg/
(*P <0.05, ****P <0.001). (B) Levels of human TGF-β1 levels in the supernatant
non-Tregs (*P <0.05). (C) Stimulation with interferon-gamma (IFNγ) and tumo
TGF-β1 (*P <0.05).polarisation is a key event in hAEC-mediated lung repair
[10,20], the findings from the present study suggest that
Treg expansion/induction is a crucial requirement for
hAEC-mediated macrophage polarisation. Collectively,
these data indicate that Treg induction/expansion is cen-
tral to hAEC-mediated lung repair, serving as a major
driver for macrophage polarisation.
hAECs induced the expansion of endogenous Tregs in
FoxP3-GFP C57Bl6 mice as well as adoptively trans-
ferred Tregs in Rag1−/− mice. A small proportion of the
adoptively transferred non-Tregs differentiated into
Tregs in vivo when hAECs were co-administered. The
likely mechanism for this is via hAEC-derived TGFβ.
That transcription of TGFβ was increased followingell (Treg) maturation via transforming growth factor-beta 1
ranscription and green fluorescent protein (GFP) expression. This was
mL). TGFβ was used as a positive control to induce FoxP3+ transcription
of hAECs were significantly elevated after 5 days co-cultured with
ur necrosis factor-alpha (TNFα) significantly increased gene expression of
Tan et al. Stem Cell Research & Therapy 2015, 6:8 Page 10 of 12
http://stemcellres.com/content/6/1/8exposure to IFNγ and TNFα is worth noting since TGFβ
has been shown to be a potent inducer of FoxP3 tran-
scription in naïve CD4+ T cells [28]. Another consider-
ation is the process of trogocytosis, where cell-to-cell
transfer of HLA-G from hAECs to effector T cells may
account for the acquisition of a Treg phenotype inde-
pendent of FoxP3 transcription [29]. These events may
explain the minor improvements in tissue-to-airspace ra-
tio and increase in M2 polarisation in the non-Treg +
hAEC group. That adoptively transferred non-Tregs did
not wholly restore hAEC-mediated lung repair is likely
due to the criteria by which we selected the non-Treg
cells. For this study, we selected for CD45+FoxP3− cells
by flow sorting. One limitation of such a gating strategy
is that non-T cells are also included. This includes neu-
trophils, macrophages, and dendritic cells, which are un-
able to acquire a FoxP3+ phenotype or transdifferentiate
into Tregs. The outcomes observed in the present study
are likely a reflection of this.
The reduction in macrophage infiltration and polarisa-
tion of macrophages from M1 to M2 was observed only
in the cohort of Rag1−/− animals that received hAECs
after adoptive transfer of Tregs (hAEC + Treg). This was
surprising because we have previously shown that
hAECs can directly influence macrophage polarity andFigure 6 Schematic illustration of potential mechanisms of human am
stimuli from inflammatory cytokines such as interferon-gamma (IFNγ) and t
growth factor-beta (TGF-β), thus reducing inflammation by inhibiting effect
regulatory T cells (Tregs), which polarises surrounding resident macrophage
of resolution by increasing their phagocytic activity through mannose rece
Arg-1 and found in inflammatory zone protein-1 (FIZZ-1), which are also exphagocytic activity, at least in vitro, without the presence
of Tregs [10]. We believe that the different prevailing
cytokine environments explain the apparent inconsist-
ency between in vitro and in vivo observations. In vivo
in the absence of Treg-released IL-10, the predominant
cytokines in the lungs are Th1 cytokines such as TNFα
and IL-6 [30] and IFNγ [31]. These promote a Th1 in-
flammatory environment where M1 macrophages will
predominate. The presence of Tregs would then alter
the Th 1-Th 2 balance in favour of M2 macrophages.
Mature Tregs then release IL-10, which helps to polarise
macrophages from M1 to M2 and thus promote lung re-
pair. This suggests that hAEC repair of pulmonary fibro-
sis may begin with the expansion of the local Treg
population, which triggers macrophage polarisation, ra-
ther than acting through the direct actions of hAECs.
Our proposed model of cellular crosstalk is detailed in
Figure 6.
In addition to their effects on macrophage polarisation,
Tregs have been reported to play a role in modulating the
alveolar inflammatory milieu following lipopolysaccharide
(LPS)-induced acute lung injury, in which adoptive trans-
fer of Tregs reduced inflammatory cytokines, including
TNFα, monocyte chemoattractant protein-1 (MCP-1),
RANTES (regulated on activation, normal T cell expressednion epithelial cell (hAEC)-mediated immune regulation. Upon
umour necrosis factor-alpha (TNFα), (i) hAECs synthesize transforming
or T-cell proliferation. (ii) TGFβ induces maturation of T cells into
s toward an M2 phenotype. (iii) M2 macrophages begin the cascade
ptor, CD206. (iv) Repair is followed closely by pro-angiogenic factors
pressed by M2 macrophages.
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injury, the adoptive transfer of Tregs resolved fibrosis by
reducing fibrocyte recruitment along the CXCL12-CXCR4
axis [25].
With regard to potential cell therapies for lung disease,
there are some similarities between hAEC- and MSC-
mediated Treg induction. For example, both rely on
TGFβ and involve M2 polarised macrophages [33].
However, unlike MSCs, hAECs do not appear to require
monocytes as accessory cells [33]. Interestingly, a study
by Liu and colleagues [11] using a mouse model of mul-
tiple sclerosis showed that the therapeutic effects of
hAEC treatment did not correspond to Treg numbers
despite increased TGFβ by hAECs. This finding, taken
together with the observations in the present study, sug-
gests that the therapeutic mechanisms of hAEC action
may be specific to the underlying injury.
The effective clinical translation of bench observations
relating to protective or therapeutic benefit of stem cells
and stem-like cells will require better understanding of
their mechanisms of action. The importance of under-
standing the mechanism of action of cell-based therapies
was highlighted at the NIH-National Heart, Lung, and
Blood Institute workshop in November 2012 [23]. Cell-
based therapy has been touted as ‘the next pillar of
medicine’ [34], given capabilities that extend beyond
small molecules and biologics. Understanding the mech-
anisms by which hAECs exert their reparative or pro-
tective effects will aid the development of hAEC-based
therapies. Indeed, the elucidation of critical immuno-
logical events will aid the design of informative clinical
trials.
Conclusions
hAECs require Tregs for polarisation of macrophage from
M1 to M2. In the process of mediating lung repair, hAECs
induced Treg expansion and differentiation of T cells to
FoxP3+ Tregs. Understanding how hAECs, and other stem
cells, exert immunomodulatory and reparative effects is
important in the clinical translation pipeline.
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Additional file 1: Figure S1. Gating strategy for flow cytometric sorting
of Foxp3+ regulatory T cells (Tregs). (A) Cells were gated based on side
and forward scatter to exclude cellular debris. (B) Singlets were then
selected. (C) CD45+ leukocytes were gated from singlets, and FoxP3+
Tregs were selected based on green fluorescent protein (GFP) expression.
Figure S2. Gating strategy for flow cytometric analysis of macrophage
polarity. (A) Leukocytes were isolated from the lung of Rag1−/− mice and
analysed by flow cytometry. Cellular debris was excluded and cells were
identified based on side and forward scatter. (B) Doublets were then
excluded. (C) This cell population was further gated for total leukocyte
population based on CD45 expression. (D) The macrophage population
was identified based on double positive expression of pan-macrophage
markers; F4/80 and CD11b. (E,F) Gating strategy for polarity ofmacrophages: Cells that are F4/80+CD11b+ were gated for macrophage
M1- and M2-specific surface markers CD86 and CD206, respectively. Flow
cytometric data for M1/M2 macrophages in this manuscript are presented
as percentage of CD45+ cells.
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